Case Studies from across the Catapults
- Skills (11),
- Regional growth (18),
- Highlights (27),
- Equality, Diversity and Inclusion (12),
- International (12),
- Academic engagement (19),
- Net Zero (23),
- Health (18),
- Digital technologies (18),
- Business growth (29),
- Supply chains (6),
- Leveraging Investment (19),
Themes (Reset)
- Skills
- Regional growth
-
- Equality, Diversity and Inclusion
- International
- Academic engagement
- More
Driving growth and prosperity across UK innovation
We form a crucial link in the UK’s rich innovation ecosystem – helping organisations to demonstrate and de-risk their innovation strategies and to build internal capability that attracts further investment, creates jobs, trade and sustainable prosperity.
We work across multiple sectors such as health, net zero, digitisation and are building partnerships that helping the UK to fight dementia and cancer, power electric vehicles, deliver 5G, drive low-carbon technologies from home heating to wind energy, create opportunities from space orbit data, create systems and places that enhance quality of life and so much more.
Take a look at a few examples of how Catapults are making a difference.
- Cross-Catapult (2),
- Cell and Gene Therapy (15),
- Compound Semiconductor Applications (12),
- Connected Places (13),
- Digital (14),
- Energy Systems (14),
- High Value Manufacturing (18),
- Medicines Discovery (16),
- Offshore Renewable Energy (16),
- Satellite Applications (14),
Catapults (Reset)
Medicines Discovery
Case Study
Alchemab Therapeutics secures private funding for new treatments following collaboration
In 2021 Alchemab and Medicines Discovery Catapult (MDC) collaborated on a Huntington’s disease focussed project, which supported Alchemab in securing significant private investment.
Medicines Discovery
Case Study
The Psychiatry Consortium – exploring new treatments for mental health conditions
Medicines discovery for challenging diseases requires a collaborative approach with a patient focus. In 2019 the Medicines Discovery Catapult established the Psychiatry Consortium as one of its patient focussed partnerships. It is a strategic collaboration of two leading medical research charities and seven international pharmaceutical companies, focusing on the unmet therapeutic needs of people living with mental health conditions.
Page 1 of 1